Results 81 to 90 of about 14,047 (222)

Aspects on endoscopic characterization and clinical management of Barrett's esophagus [PDF]

, 2017
Barrett's esophagus (BE) is considered to result from prolonged gastroesophageal reflux and is the only known precursor of esophageal adenocarcinoma. The clinical management of BE patients aims to control esophageal reflux to reduce mucosal injury and
Silva, Francisco Baldaque
core   +2 more sources

GERD and Upper Aerodigestive Tract Cancer Risk: A Systematic Review and Meta‐Analysis

The Laryngoscope, Volume 136, Issue 5, Page 2008-2017, May 2026.
ABSTRACT Objective Gastroesophageal reflux disease (GERD) is highly prevalent, yet its association with upper aerodigestive tract (UADT) cancers beyond esophageal adenocarcinoma remains incompletely defined. This systematic review and meta‐analysis aimed to quantify the risk of specific UADT cancers in individuals with GERD.
Janice Huang, Nicolas Jo, Garret Forman, Tonya Aaron, Sophia Peifer, Soumil Prasad, Luke van Leeuwen, Laura Wild, Nicholas DiStefano, Zhibin Chen, Elizabeth Franzmann   +10 more
wiley   +1 more source

Diagnosis and Management of Barrett’s Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines

The Korean Journal of Gastroenterology, 2019
Barrett’s esophagus (BE) is one of the most prominent diseases in Western countries because of its potential to progress to dysplasia or adenocarcinoma. Recently, the American College of Gastroenterology (ACG), American Gastroenterology Association (AGA),
Ah Young Yoo, Moon Kyung Joo
doaj   +1 more source

Automated Creak Identifies Laryngeal Dystonia During Conversational Speech

The Laryngoscope, Volume 136, Issue 5, Page 2270-2277, May 2026.
This study evaluated whether automated creak distinguished speakers with adductor laryngeal dystonia (AdLD), muscle tension dysphonia (MTD), and those without voice disorders during conversational speech. Automated creak estimates were able to differentiate speakers with AdLD from MTD and controls with similar performance across different types of ...
Daria A. Dragicevic, Cara E. Sauder, Daniel P. Buckley, Laura E. Toles, Lauren F. Tracy, J. Pieter Noordzij, Gregory A. Grillone, Ted Mau, John Paul Giliberto, Tanya K. Meyer, Albert L. Merati, Tanya L. Eadie, Cara E. Stepp, Katherine L. Marks   +13 more
wiley   +1 more source

O critério de positividade para a análise imunoistoquímica da p53 na confirmação da displasia do esôfago de Barrett faz diferença? Does positive criterium for p53 immunohistochemical analysis in the confirmation of Barrett's dysplasia make difference?

Arquivos de Gastroenterologia, 2005
RACIONAL: O esôfago de Barrett é uma complicação da doença do refluxo gastroesofágico com importante potencial de malignização. Relata-se que a expressão do marcador tumoral p53 se acentua com a progressão displasia-adenocarcinoma.
César Vivian Lopes, Júlio C. Pereira-Lima, Antônio Atalíbio Hartmann, Eunice Tonelotto, Karina Salgado   +4 more
doaj   +1 more source

Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. [PDF]

, 2007
BACKGROUND: The development of oesophageal adenocarcinoma is generally closely associated with the presence of a specialised intestinal-type epithelium such as that found in Barrett's oesophagus (BO).
AGNESE, Valentina, ARAGONA, Federico, BAZAN, Viviana, CABIBI, Daniela, CALCARA, Donatella, COLUCCI, G, FIORENTINO, Eugenio, GEBBIA, Nicolo', INTRIVICI, Chiara, PANTUSO, Gianni, RUSSO, Antonio, TERRASI, Marianna   +11 more
core   +1 more source

Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis

ACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective Gastroesophageal reflux disease (GERD) affects up to 90% of patients with systemic sclerosis (SSc). Chronic esophageal acid exposure can result in complications including the formation of esophageal strictures (ES). Proton pump inhibitors can alter gastric acid pH and improve GORD symptoms; however, there have been no recent studies ...
Alannah Quinlivan, Dylan Hansen, Wendy Stevens, Nava Ferdowsi, Susanna Proudman, Jennifer Walker, Joanne Sahhar, Gene‐Siew Ngian, Diane Apostolopoulos, Lauren V. Host, Chamara Basnayake, Kathleen Morrisroe, Laura Ross, Mandana Nikpour   +13 more
wiley   +1 more source

High expression of Cathepsin E in tissues but not blood of patients with Barrett’s esophagus and adenocarcinoma [PDF]

, 2014
Background Cathepsin E (CTSE), an aspartic proteinase, is differentially expressed in the metaplasia–dysplasia–neoplasia sequence of gastric and colon cancer.
Bobryshev, Yuri V., Botelho, Natalia K., Falkenback, Dan,, Fisher, Oliver M., Freeman, Araluen K., Levert-Mignon, Angelique J., Lord, Reginald V., Lord, Sarah J., Lund University., Thomas, Melissa L., Wettstein, Antony, Whiteman, David C.   +11 more
core   +2 more sources

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the International BEACON Consortium [PDF]

, 2010
BackgroundPrevious studies that showed an association between smoking and adenocarcinomas of the esophagus and esophagogastric junction were limited in their ability to assess differences by tumor site, sex, dose–response, and duration of cigarette ...
Abnet, C.C., Bernstein, L., Brown, L.M., Casson, A.G., Chow, W.H., Cook, M.B., Corley, D.A., Freedman, N.D., Gammon, M.D., Giffen, C., Kamangar, F., Linda, Sharpe, Murray, Liam, Nyren, O., Pandeya, N., Risch, H.A., Vaughan, T.L., Ward, M.H., Webb, P.M., Whiteman, D.C., Wu, P.M., Ye, W.   +21 more
core   +1 more source

Пищевод Баррета в структуре гастроэзофагеальной рнфлюксной болезни: современные представления [PDF]

, 2010
БАРРЕТА ПИЩЕВОДДУОДЕНО-ГАСТРАЛЬНЫЙ ...
Конорев, М. Р., Мастыкова, Е. К., Матвеенко, М. Е.   +2 more
core